Keywords
Last Name
Institution

Michael C. Kim

TitleASSISTANT PROFESSOR
InstitutionMount Sinai
DepartmentCardiology
Address

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Kahn MR, Robbins MJ, Kim MC, Fuster V. The role of fibrates in chronic kidney disease and diabetes mellitus. Nat Rev Cardiol. 2013 Sep; 10(9):547.
      View in: PubMed
    2. Kovacic JC, Limaye AM, Sartori S, Lee P, Patel R, Chandela S, Trost B, Roy S, Harari R, Narechania B, Karajgikar R, Kim MC, Krishnan P, Moreno P, Baber U, Mehran R, Dangas G, Kini AS, Sharma SK. Comparison of six risk scores in patients with triple vessel coronary artery disease undergoing PCI: Competing factors influence mortality, myocardial infarction, and target lesion revascularization. Catheter Cardiovasc Interv. 2013 Nov 15; 82(6):855-68.
      View in: PubMed
    3. Kim M, Muntner P, Sharma S, Choi JW, Stoler RC, Woodward M, Mann DM, Farkouh ME. Assessing patient-reported outcomes and preferences for same-day discharge after percutaneous coronary intervention: results from a pilot randomized, controlled trial. Circ Cardiovasc Qual Outcomes. 2013 Mar 1; 6(2):186-92.
      View in: PubMed
    4. Kahn MR, Robbins MJ, Kim MC, Fuster V. Management of cardiovascular disease in patients with kidney disease. Nat Rev Cardiol. 2013 May; 10(5):261-73.
      View in: PubMed
    5. Tang GH, Kim MC, Pinney SP, Anyanwu AC. Failed repeated thrombolysis requiring left ventricular assist device pump exchange. Catheter Cardiovasc Interv. 2013 May; 81(6):1072-4.
      View in: PubMed
    6. Narayan RL, Vaishnava P, Kim M. Radial artery perforation during transradial catheterization managed with a coronary polytetrafluoroethylene-covered stent graft. J Invasive Cardiol. 2012 Apr; 24(4):185-7.
      View in: PubMed
    7. Taylor-Sutton JE, Kim MC. Very late stent thrombosis approximately 7 years after deployment and one-week cessation of dual antiplatelet therapy. J Invasive Cardiol. 2011 Dec; 23(12):E273-6.
      View in: PubMed
    8. Kovacic JC, Mehran R, Karajgikar R, Baber U, Suleman J, Kim MC, Krishnan P, Dangas G, Sharma SK, Kini A. Female gender and mortality after percutaneous coronary intervention: results from a large registry. Catheter Cardiovasc Interv. 2012 Oct 1; 80(4):514-21.
      View in: PubMed
    9. Kahn MR, Fallahi A, Kim MC, Esquitin R, Robbins MJ. Coronary artery disease in a large renal transplant population: implications for management. Am J Transplant. 2011 Dec; 11(12):2665-74.
      View in: PubMed
    10. Baber U, Mehran R, Sharma SK, Brar S, Yu J, Suh JW, Kim HS, Park SJ, Kastrati A, de Waha A, Krishnan P, Moreno P, Sweeny J, Kim MC, Suleman J, Pyo R, Wiley J, Kovacic J, Kini AS, Dangas GD. Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials. J Am Coll Cardiol. 2011 Oct 4; 58(15):1569-77.
      View in: PubMed
    11. Muntner P, Mann DM, Woodward M, Choi JW, Stoler RC, Shimbo D, Farkouh ME, Kim MC. Predictors of low clopidogrel adherence following percutaneous coronary intervention. Am J Cardiol. 2011 Sep 15; 108(6):822-7.
      View in: PubMed
    12. Bashey S, Muntner P, Kini AS, Esquitin R, Razzouk L, Mathewkutty S, Wildman RP, Carson AP, Kim MC, Moreno PR, Sharma SK, Farkouh ME. Clustering of metabolic abnormalities among obese patients and mortality after percutaneous coronary intervention. Am J Cardiol. 2011 May 15; 107(10):1415-20.
      View in: PubMed
    13. Licurse A, Kim MC, Dziura J, Forman HP, Formica RN, Makarov DV, Parikh CR, Gross CP. Renal ultrasonography in the evaluation of acute kidney injury: developing a risk stratification framework. Arch Intern Med. 2010 Nov 22; 170(21):1900-7.
      View in: PubMed
    14. Chikwe J, Kim M, Goldstone AB, Fallahi A, Athanasiou T. Current diagnosis and management of left main coronary disease. Eur J Cardiothorac Surg. 2010 Oct; 38(4):420-8.
      View in: PubMed
    15. Fallahi A, Kim M. Initial experience of removal of 10-French sheaths using the 8-French Angio-Seal vascular closure device. J Invasive Cardiol. 2010 Mar; 22(3):130-1.
      View in: PubMed
    16. Kini AS, Rafael OC, Sarkar K, Rajdev S, Jakkula M, Mares AM, Kaplish D, Krishnan P, Kim MC, Sharma SK. Changing outcomes and treatment strategies for wire induced coronary perforations in the era of bivalirudin use. Catheter Cardiovasc Interv. 2009 Nov 1; 74(5):700-7.
      View in: PubMed
    17. Rosenblum MA, Robbins MJ, Farkouh ME, Winston JA, Kim MC. Diminished benefits of drug-eluting stents versus bare metal stents in patients with severe renal insufficiency. Nephron Clin Pract. 2009; 113(3):c198-202.
      View in: PubMed
    18. Kini AS, Sarkar K, Rafael OC, Jakkula M, Kaplish D, Lee P, Suleman J, Krishnan P, Kim MC, Sharma SK. Serum creatinine ratio: a novel predictor of mortality after percutaneous coronary intervention in patients with normal and abnormal renal function. Catheter Cardiovasc Interv. 2009 Jul 1; 74(1):49-55.
      View in: PubMed
    19. Baber U, Kini AS, Sharma SK, Kim MC, Farkouh ME, Muntner P. Thrombolysis In Myocardial Infarction (TIMI) risk score and mortality in patients with advanced chronic kidney disease and on dialysis. Am J Cardiol. 2009 Jun 1; 103(11):1513-7.
      View in: PubMed
    20. Kini AS, Muntner P, Moreno PR, Mann D, Krishnan P, Kim MC, Rafael OC, Farkouh ME, Sharma SK. Relation of high-density lipoprotein cholesterol to mortality after percutaneous coronary interventions in patients with low-density lipoprotein <70 mg/dl. Am J Cardiol. 2009 Feb 1; 103(3):350-4.
      View in: PubMed
    21. Kini AS, Chen VH, Krishnan P, Lee P, Kim MC, Mares A, Suleman J, Moreno PR, Sharma SK. Bolus-only versus bolus + infusion of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention. Am Heart J. 2008 Sep; 156(3):513-9.
      View in: PubMed
    22. Rajdev S, Krishnan P, Irani A, Kim MC, Moreno PR, Sharma SK, Kini AS. Clinical application of prophylactic percutaneous left ventricular assist device (TandemHeart) in high-risk percutaneous coronary intervention using an arterial preclosure technique: single-center experience. J Invasive Cardiol. 2008 Feb; 20(2):67-72.
      View in: PubMed
    23. Kunamneni PB, Rajdev S, Krishnan P, Moreno PR, Kim MC, Sharma SK, Kini AS. Outcome of intracoronary stenting after failed maximal medical therapy in patients with symptomatic myocardial bridge. Catheter Cardiovasc Interv. 2008 Feb 1; 71(2):185-90.
      View in: PubMed
    24. Kini AS, Kim MC, Moreno PR, Krishnan P, Ivan OC, Sharma SK. Comparison of coronary flow reserve and fractional flow reserve in patients with versus without diabetes mellitus and having elective percutaneous coronary intervention and abciximab therapy (from the PREDICT Trial). Am J Cardiol. 2008 Mar 15; 101(6):796-800.
      View in: PubMed
    25. Lubitz SA, Duvall WL, Kim MC, Henzlova MJ. Dobutamine-induced myocardial infarction with normal coronary arteries during stress SPECT myocardial perfusion imaging. J Nucl Cardiol. 2007 Jul; 14(4):613-6.
      View in: PubMed
    26. Anand SX, Kim MC, Kamran M, Sharma SK, Kini AS, Fareed J, Hoppensteadt DA, Carbon F, Cavusoglu E, Varon D, Viles-Gonzalez JF, Badimon JJ, Marmur JD. Comparison of platelet function and morphology in patients undergoing percutaneous coronary intervention receiving bivalirudin versus unfractionated heparin versus clopidogrel pretreatment and bivalirudin. Am J Cardiol. 2007 Aug 1; 100(3):417-24.
      View in: PubMed
    27. Kim MC. Vascular closure devices. Cardiol Clin. 2006 May; 24(2):277-86, vii.
      View in: PubMed
    28. Jang JJ, Kim M, Gray B, Bacharach JM, Olin JW. Claudication secondary to Perclose use after percutaneous procedures. Catheter Cardiovasc Interv. 2006 May; 67(5):687-95.
      View in: PubMed
    29. Wyatt CM, Kim MC, Winston JA. Therapy insight: how changes in renal function with increasing age affect cardiovascular drug prescribing. Nat Clin Pract Cardiovasc Med. 2006 Feb; 3(2):102-9.
      View in: PubMed
    30. Nair AP, Nemirovsky D, Kim M, Geer EB, Farkouh ME, Winston J, Halperin JL, Robbins MJ. Elevated homocysteine levels in patients with end-stage renal disease. Mt Sinai J Med. 2005 Nov; 72(6):365-73.
      View in: PubMed
    31. Kini AS, Moreno PR, Steinheimer AM, Prattipati M, Suleman J, Kim MC, Sharma SK. Effectiveness of the stent pull-back technique for nonaorto ostial coronary narrowings. Am J Cardiol. 2005 Oct 15; 96(8):1123-8.
      View in: PubMed
    32. Winslow RD, Sharma SK, Kim MC. Restenosis and drug-eluting stents. Mt Sinai J Med. 2005 Mar; 72(2):81-9.
      View in: PubMed
    33. Sharma SK, Choudhury A, Lee J, Kim MC, Fisher E, Steinheimer AM, Kini AS. Simultaneous kissing stents (SKS) technique for treating bifurcation lesions in medium-to-large size coronary arteries. Am J Cardiol. 2004 Oct 1; 94(7):913-7.
      View in: PubMed
    34. Kini AS, Lee P, Marmur JD, Agarwal A, Duffy ME, Kim MC, Sharma SK. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality. Am J Cardiol. 2004 Jan 1; 93(1):18-23.
      View in: PubMed
    35. Doshi SN, Kini A, Kim MC, Payne N, Kamran M, Sherman W, Marmur JD, Sharma SK. A comparative study of rotational atherectomy in acute and stable coronary syndromes in the modern era. Am J Cardiol. 2003 Dec 15; 92(12):1404-8.
      View in: PubMed
    36. Kini AS, Lee PC, Mitre CA, Kim MC, Kamran M, Duffy ME, Marmur JD, Sharma SK. Prediction of outcome after percutaneous coronary intervention for the acute coronary syndrome. Am J Med. 2003 Dec 15; 115(9):708-14.
      View in: PubMed
    37. Gomberg-Maitland M, Kim MC, Fuster V. A stratified approach to the treatment of a symptomatic myocardial bridge. Clin Cardiol. 2002 Oct; 25(10):484-6.
      View in: PubMed
    38. Doshi SN, Kim MC, Sharma SK, Fuster V. Images in cardiovascular medicine. Right and left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Circulation. 2002 Jul 9; 106(2):e3-4.
      View in: PubMed
    39. Doshi SN, Sharma SK, Kim MC. Normal coronary arteries and isolated, regional, left ventricular dysfunction in myotonic dystrophy: a case report. Int J Cardiol. 2002 May; 83(2):191-3.
      View in: PubMed
    40. Kini AS, Mitre CA, Kamran M, Suleman J, Kim M, Duffy ME, Marmur JD, Sharma SK. Changing trends in incidence and predictors of radiographic contrast nephropathy after percutaneous coronary intervention with use of fenoldopam. Am J Cardiol. 2002 Apr 15; 89(8):999-1002.
      View in: PubMed
    41. Kim MC, Kini A, Sharma SK. Refractory angina pectoris: mechanism and therapeutic options. J Am Coll Cardiol. 2002 Mar 20; 39(6):923-34.
      View in: PubMed
    42. Kini AS, Mitre CA, Kim M, Kamran M, Reich D, Sharma SK. A protocol for prevention of radiographic contrast nephropathy during percutaneous coronary intervention: effect of selective dopamine receptor agonist fenoldopam. Catheter Cardiovasc Interv. 2002 Feb; 55(2):169-73.
      View in: PubMed
    Kim's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067